Form 4: Biodesix Director Boosts Stake with Share Purchase
Insider Transaction Report
Biodesix Director and 10% Owner Jack W. Schuler acquired 82,465 shares of common stock through a pre-arranged trading plan.
Summary
- Jack W. Schuler, a Director, 10% Owner, and Emeritus Director of BIODESIX INC (BDSX), purchased common stock.
- The transaction occurred on January 22, 2026.
- Mr. Schuler acquired 82,465 shares of common stock at a weighted average price of $10.9569 per share.
- The purchase price ranged from $10.675 to $11.10 per share.
- The transaction was executed pursuant to a Rule 10b5-1(c) trading plan.
- Following this transaction, Mr. Schuler indirectly beneficially owns 1,463,210 shares through the Jack W. Schuler Living Trust and 750,000 shares through the Jack W. Schuler 2025 GRAT.
Sentiment
Score: 8
Explanation: The significant purchase of shares by a director and 10% owner, especially through a pre-arranged plan, signals strong confidence in the company's valuation and future performance.
Positives
- A director and 10% owner, Jack W. Schuler, increased his stake in Biodesix Inc. by purchasing 82,465 shares, signaling strong insider confidence.
- The purchase was made through a Rule 10b5-1(c) plan, indicating a pre-planned investment strategy.
Future Outlook
NA
Industry Context
NA
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Insider Trading Plan | The reported transaction was made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan for the purchase or sale of equity securities. | 01/22/2026 | Indicates a pre-arranged trading strategy designed to satisfy affirmative defense conditions against insider trading allegations, promoting transparency and compliance. |
Related Party Transactions
- Jack W. Schuler, a Director and 10% Owner of Biodesix Inc., purchased 82,465 shares of common stock, which constitutes a related party transaction.
Stakeholder Impact
- Shareholders may interpret the insider purchase as a positive signal, potentially increasing confidence in the company's stock and future performance.
Key Dates
| Date | Description |
|---|---|
| 01/22/2026 | Date of earliest transaction (purchase of common stock) |
| 01/26/2026 | Signature date of the reporting person's attorney-in-fact |
Recommendation
buyThe significant purchase of shares by a director and 10% owner, Jack W. Schuler, through a Rule 10b5-1(c) plan, indicates strong insider confidence in Biodesix's future. This action by a well-informed individual suggests a belief that the stock is undervalued or poised for growth, making it a compelling 'buy' signal for investors.
Keywords
Biodesix, BDSX, Insider Trading, Form 4, Stock Purchase, Director, 10% Owner, Equity Acquisition, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.